switching from glp 1 to tirzepatide vs. Semaglutide: What You Should Know How Does Tirzepatide Work? |

Abstract Objective: This study aimed to explore the risk factors for gastrointestinal side effects (GISEs) in patients with type 2 diabetes mellitus (T2DM) during treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) based on real-world data and to develop a prediction model for GLP-1RA-related GISEs

Steinwachs, M

adults affected by obesity, treatment options have been shifting from lifestyle benefits to core benefits

PMID: 40638872

Clinical Trial Data Show Reduced Drug Response To understand how GLP-1 resistance affects treatment outcomes, the team analyzed data from several clinical trials involving people with diabetes

Los nios con deficiencia de L-Carnitina se caracterizan por sntomas como: bajo peso , disminucin de la masa corporal, debilidad muscular e infecciones recurrentes